Press release
2025-2034 Pharmerging Market Evolution: Disruptions, Innovations, and Untapped Opportunities
Pharmerging Market
What Is the Expected CAGR for the Pharmerging Market Through 2025?
The size of the pharmerging market has expanded significantly over the past few years. Its projected growth is slated to rise from $2042.23 billion in 2024 to $2259.20 billion in 2025, with a compound annual growth rate (CAGR) of 10.6%. Factors contributing to this growth during the historical period include the increase in healthcare spending, the surge in chronic illness cases, the expansion of the middle-class demographic, escalating urbanization, and heightened consciousness about health and wellness.
What's the Projected Size of the Global Pharmerging Market by 2029?
The size of the pharmerging market is anticipated to experience swift expansion in the upcoming years, reaching a value of $3339.19 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 10.3%. Factors such as increased demand for specialty drugs, government health initiatives, enhanced healthcare awareness and literacy, as well as e-commerce integration in pharmaceuticals are all contributing to this growth over the forecast period. Key upcoming trends for this period include advancement in personalized medicine strategies, digital health platform integration, innovation in drug delivery technology, new health financing models, and the implementation of supply chain technologies.
View the full report here:
https://www.thebusinessresearchcompany.com/report/pharmerging-global-market-report
Top Growth Drivers in the Pharmerging Industry: What's Accelerating the Market?
The pharmerging market's growth is set to be fuelled by the increasing healthcare expenditure. This refers to the complete sum of money utilized for medical services, cures, amenities, investigation, and public health programs to sustain or boost health results. The surge in healthcare expenditure is attributed to the ageing population that necessitates more medical attention, cures, and prolonged healthcare services. By enhancing medical services accessibility, facilitating superior infrastructure growth, and encouraging the broader adoption of affordable medicines, this augment in healthcare expenditure is propelling the pharmerging market's growth. As an example, the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, reported that national health expenditures (NHE) saw a 7.5% increase, reaching $4.9 trillion in 2023, forming 17.6% of the gross domestic product (GDP) in December 2024. Furthermore, it is predicted that between 2023 and 2032, the average national health expenditures (NHE) will rise at an average annual rate of 5.6%, leading to an uptick in the health spending fraction of the domestic product (GDP) from 17.3% in 2022 to 19.7% in 2032. Consequently, the escalating healthcare expenditure is fostering the pharmerging market's growth.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28298&type=smp
What Trends Will Shape the Pharmerging Market Through 2029 and Beyond?
Key players in the pharmerging market are centering their efforts on creating pioneering solutions like mixed drug treatments to manage intricate health issues and bolster the effectiveness of outcomes. Mixed drug treatments are therapies that utilize at least two pharmaceutical drugs combined in one course to maximize efficiency and target several aspects of a health issue at once. For example, in June 2024, Akums Drugs and Pharmaceuticals Limited, a contract development and manufacturing company based in India, introduced their newest approved drug combination, the Rabeprazole + Levosulpiride SR capsules, sanctioned by the Drug Controller General of India (DCGI) to manage gastroesophageal reflux disease (GERD) and miscellaneous gastrointestinal disorders. These capsules pair Rabeprazole, which controls the production of stomach acid, with Levosulpiride, an agent that enhances the motility of the stomach and intestine, hence preventing acid reflux. Offering relief from GERD symptoms, this dual-action mechanism uniformly decreases acid secretion and boosts gastrointestinal activity.
What Are the Main Segments in the Pharmerging Market?
The pharmerging market covered in this report is segmented as
1) By Product Type: Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology, Generics
2) By Indication: Lifestyle Diseases, Cancer And Autoimmune Diseases, Infectious Diseases, Other Indications
3) By Formulation: Solid Oral, Liquid Oral, Injectable, Topical, Other Formulation Types
4) By Application: Therapeutic, Diagnostic, Preventive, Research And Development
5) By Distribution Channel: Hospitals And Clinics, Retail Pharmacies, Online Marketplaces, Wholesale Distributors, Direct-To-Consumer
Subsegments:
1) By Pharmaceuticals: Small Molecule Drugs, Biological Drugs, Over The Counter Drugs, Patented Drugs, Branded Generics, Vaccines
2) By Medical Devices: Diagnostic Imaging Devices, Surgical Instruments, Patient Monitoring Devices, Therapeutic Devices, Implantable Devices
3) By Diagnostics: In Vitro Diagnostics, Molecular Diagnostics, Imaging Diagnostics, Point Of Care Testing, Companion Diagnostics, Digital Diagnostics
4) By Biotechnology: Genomic Medicine, Cell Therapy, Gene Therapy, Monoclonal Antibodies, Biosimilars
5) By Generics: Oral Solid Dosage Generics, Injectable Generics, Topical Generics, Inhalable Generics, Ophthalmic Generics, Transdermal Generics
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28298&type=smp
Which Top Companies are Driving Growth in the Pharmerging Market?
Major companies operating in the pharmerging market are Pfizer Inc., Roche Holding AG, AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, GE Healthcare Technologies Inc., Alembic Ltd., Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Aspen Pharmacare Holdings Limited, Zydus Lifesciences Limited, Lupin Limited, and Beximco Pharmaceuticals Ltd.
Which Regions Will Dominate the Pharmerging Market Through 2029?
North America was the largest region in the pharmerging market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharmerging report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28298
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2025-2034 Pharmerging Market Evolution: Disruptions, Innovations, and Untapped Opportunities here
News-ID: 4213435 • Views: …
More Releases from The Business Research Company
Leading Companies Fueling Growth and Innovation in the Sun Care Products Market
The sun care products market is on track for substantial expansion as consumer awareness about skin protection intensifies worldwide. With evolving preferences and technological advancements shaping product offerings, this sector is set to witness robust growth in the coming years. Let's explore the market's size projections, key players, emerging trends, and major segments driving its development through 2030.
Projected Size and Growth Trajectory of the Sun Care Products Market
The…
Future Perspectives: Key Trends Shaping the Styrene Butadiene Rubber (SBR) Based …
The styrene butadiene rubber (SBR) based adhesive market is on track for notable growth as we approach 2030. Driven by a variety of factors including expanding infrastructure projects and rising demand across multiple industries, this sector is poised for steady expansion. Let's explore the market's size projections, key players, emerging trends, and the main segments shaping its future.
Projected Growth and Market Size of Styrene Butadiene Rubber Based Adhesives
The…
Emerging Sub-Segments Transforming the Stearic Acid Market Landscape
The stearic acid market is poised for significant expansion in the coming years, driven by evolving demand across various industries. This report explores the projected market size, leading companies, key trends, and segment analysis shaping the future of this vital chemical.
Stearic Acid Market Size and Growth Outlook
The stearic acid market is set to grow robustly, reaching a valuation of $54.63 billion by 2030. This represents a compound annual…
Market Trend Insights: The Impact of Recent Innovations on the Specialty Pestici …
The specialty pesticides sector is on the verge of significant expansion as global agricultural practices continue to evolve. Driven by increasing demand for crop protection and sustainable farming techniques, this market is set to experience robust growth in the coming years. Let's explore the market's anticipated value, leading companies, emerging trends, and detailed segmentation to gain a comprehensive understanding of this dynamic industry.
Projected Market Size and Growth Expectations for Specialty…
More Releases for Pharmerging
Pharmerging Nations Redefining Global Healthcare Growth: An In-Depth Outlook on …
The Global Pharmerging Market, valued at US$ 2.1 Bn in 2023, is set to witness rapid expansion, projected to reach US$ 7.1 Bn by 2034, growing at a strong CAGR of 11.6% from 2024 to 2034. This fast-paced growth underscores the increasing importance of pharmerging countries-an economic group representing emerging nations with accelerating pharmaceutical demand, evolving regulatory infrastructures, rising healthcare investments, and expanding patient populations. These countries, including large markets…
Pharmerging Market to Witness Astonishing Growth by 2028
The Pharmerging Market size is expected to grow at an annual average of CAGR 11% during the forecast period (2023-2029). Pharmerging refers to a group of countries with low but fast growth in the pharmaceutical market. Growing healthcare spending coupled with increasing number of private hospitals is currently driving the global pharmerging market growth. In addition, high prevalence of numerous chronic diseases and increasing consumer awareness of early detection of…
New Report Projects Strong Growth for Pharmerging Market
As per the market research report by TMR, in 2015, the global pharmerging market stood at US$552.8 mn and is predicted to reach a value of US$1.40 bn by 2024. The market is further anticipated to register a promising 11.30% CAGR from 2016 to 2024. In the last few years, Asia Pacific held a huge share of the pharmerging market and is estimated to remain in the same position over…
Pharmerging Market : 2016 - 2024 Illuminated By New Report
Global Pharmerging Market: Snapshot
The global pharmerging market is experiencing a significant rise, especially in the emerging economies across the world. The rising prevalence of non-communicable diseases, aging population, increasing life expectancy, escalating income, surging government expenditure on health care, free trade agreement, and the constant research and development are some of the key factors behind the growth of this market.
View Report: https://www.transparencymarketresearch.com/pharmerging-market.html
With the increasing incidence rate of various diseases, the…
Pharmerging Market 2016-2024 Industry Size, Shares, Research Trends
Global Pharmerging Market: Snapshot
The global pharmerging market is experiencing a significant rise, especially in the emerging economies across the world. The rising prevalence of non-communicable diseases, aging population, increasing life expectancy, escalating income, surging government expenditure on health care, free trade agreement, and the constant research and development are some of the key factors behind the growth of this market.
With the increasing incidence rate of various diseases, the demand for…
Global Pharmerging Market Research Report 2017
Global Pharmerging Industry 2017 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2017-2020.
This report on the global Pharmerging market is a rich data repository assembled with the aim of presenting before the reader a new viewpoint on the market’s present state and estimated future growth. The report compiles vast data quantitative as well as qualitative insights into the key elements of…
